BEAM
Price
$26.29
Change
+$0.78 (+3.06%)
Updated
Sep 19, 09:58 AM (EDT)
46 days until earnings call
PTGX
Price
$46.34
Change
+$1.58 (+3.53%)
Updated
Sep 19, 10:45 AM (EDT)
48 days until earnings call
Ad is loading...

BEAM vs PTGX

Header iconBEAM vs PTGX Comparison
Open Charts BEAM vs PTGXBanner chart's image
Beam Therapeutics
Price$26.29
Change+$0.78 (+3.06%)
Volume$100
CapitalizationN/A
Protagonist Therapeutics
Price$46.34
Change+$1.58 (+3.53%)
Volume$813
CapitalizationN/A
View a ticker or compare two or three
BEAM vs PTGX Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BEAM vs. PTGX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PTGX is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (BEAM: $25.51 vs. PTGX: $44.77)
Brand notoriety: BEAM and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 83% vs. PTGX: 84%
Market capitalization -- BEAM: $2.1B vs. PTGX: $2.65B
BEAM [@Biotechnology] is valued at $2.1B. PTGX’s [@Biotechnology] market capitalization is $2.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePTGX’s FA Score has 2 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PTGX’s FA Score: 2 green, 3 red.
According to our system of comparison, PTGX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • PTGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +5.76% price change this week, while PTGX (@Biotechnology) price change was -0.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.81%. For the same industry, the average monthly price growth was +7.77%, and the average quarterly price growth was +2.01%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 04, 2024.

PTGX is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+7.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($2.65B) has a higher market cap than BEAM($2.1B). PTGX YTD gains are higher at: 95.246 vs. BEAM (-6.282). PTGX has higher annual earnings (EBITDA): 156M vs. BEAM (-162.88M). BEAM has more cash in the bank: 1.01B vs. PTGX (564M). PTGX has less debt than BEAM: PTGX (11M) vs BEAM (165M). BEAM has higher revenues than PTGX: BEAM (353M) vs PTGX (319M).
BEAMPTGXBEAM / PTGX
Capitalization2.1B2.65B79%
EBITDA-162.88M156M-104%
Gain YTD-6.28295.246-7%
P/E RatioN/A16.46-
Revenue353M319M111%
Total Cash1.01B564M179%
Total Debt165M11M1,500%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPTGX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OFSFX22.690.09
+0.40%
Olstein Strategic Opportunities Adviser
LGASX65.810.03
+0.05%
ClearBridge Small Cap FI
FSMAX85.690.03
+0.04%
Fidelity Extended Market Index
BARDX10.43-0.03
-0.29%
iShares Developed Real Estate Idx Inv A
PIVYX43.30-0.15
-0.35%
Putnam International Capital Opp Y

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.27%
NTLA - BEAM
75%
Closely correlated
-0.13%
CRSP - BEAM
73%
Closely correlated
-0.64%
EDIT - BEAM
67%
Closely correlated
+0.26%
DNLI - BEAM
66%
Loosely correlated
+0.26%
PRME - BEAM
65%
Loosely correlated
-0.50%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with RCKT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
-0.31%
RCKT - PTGX
46%
Loosely correlated
-4.40%
NTLA - PTGX
45%
Loosely correlated
-0.13%
VIR - PTGX
44%
Loosely correlated
-1.51%
RCUS - PTGX
43%
Loosely correlated
-1.43%
BEAM - PTGX
41%
Loosely correlated
-0.27%
More